康健國際醫療(03886.HK)上半年盈轉虧至9396.8萬港元
格隆匯 8 月 27日丨康健國際醫療(03886.HK)公佈,截至2020年6月30日止6個月,公司實現收入4.37億港元,同比減少25.26%;公司擁有人應占期內虧損9396.8萬港元,同期則盈利1415.3萬港元,每股虧損1.25港仙。
是次未經審核綜合溢利大幅減少至未經審核綜合虧損乃主要歸因於:i)期內,2019冠狀病毒病疫情對集團業務營運產生不利影響,尤其是2020年上半年,問診集團醫療中心的病人數量顯著減少;ii)2020年上半年,集團投資物業公平值虧損增加;及iii)應占聯營公司虧損增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.